Navigation Links
Boryung and Stendhal Expand Cardiovascular Partnership in Latin America
Date:8/26/2013

Mexico City (PRWEB) August 26, 2013

Boryung Pharmaceutical Co. and Stendhal have expanded their cardiovascular partnership with a license and distribution agreement for Boryung’s Arakor Plus, an ARB combined with HTCZ for the treatment of hypertension. Stendhal will launch the product under the brand name Diarakor in 13 Latin American countries.

This agreement expands Stendhal’s cardiovascular portfolio with four additional products based on Boryung’s novel ARB Fimasartan. Stendhal will invest over $40 million in the commercialization of the Fimasartan family of products from Boryung.

Tae-hong Choi, Boryung Pharmaceutical CEO said, "We are interested in Stendhal because it is a company that shares values and a corporate culture of innovation with Boryung. This is an agreement that goes beyond economic interest since it supports a segment of the population with a major illness and whose current therapies have not resulted in a completely effective treatment."

According to Dr. Gerardo Sanchez Mejorada, Medical Director of Stendhal Mexico, "This agreement allows the companies to move closer for the benefit of the population by attacking a problem like hypertension that has been well known as a silent killer and that affects a large proportion of the population".

Boryung and Stendhal share a long-term vision focused on launching innovative cardiovascular products for the benefit of patients in Latin America. With this second license and distribution agreement between the partners, Stendhal’s Cardiovascular franchise is well-positioned to become a market leader in Latin America.

About Stendhal

Stendhal is a pharmaceutical company specialized in innovative medicine and high specialty products that offer solutions to diseases threatening human life. The company is specialized in fighting infectious diseases such as HIV/AIDS, hospital acquired infections, conditions affecting central nervous system such as Multiple Sclerosis, and Cardio Metabolic conditions like hypertension. For more information on Stendhal, please visit: http://www.stendhalpharma.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11054147.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS enlists Archimedes Inc. to expand governments use of health care modeling
2. Data release from the Allen Institute for Brain Science expands online atlas offerings
3. Financial Press: Bralorne Gold Mines Strikes Expands on its Ultra-High Grade Gold System in Canada
4. Mahvrick Expands to Brazil, Russia, India, China to Support Existing Client Customer Growth
5. Test-Med Joins Forces with Mollen to Expand its Service Offerings to its Customers
6. Expanding Access to Medicaid Would Save Lives: Study
7. Expanding Medicaid to low-income adults leads to improved health, fewer deaths
8. Boston University researchers expand synthetic biologys toolkit
9. University of Pennsylvania and Novartis form alliance to expand use of personalized T cell cancer therapy
10. Expanding database enables discoveries in emerging field of metabolomics
11. U.S. Expands SIDS Prevention Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... from third world countries to hospitals in the United States, it’s a threat ... on the current obstacles facing infection prevention and offers strategies for the healthcare ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for eating ... of disordered eating, announced today that the 2017 Symposium set a new attendance record ... countries converged on the Green Valley Resort in Las Vegas. , “We are ...
(Date:3/24/2017)... ... 24, 2017 , ... Northridge dentists, Dr. Michel ... sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has ... type, is increasingly being treated at dental offices with newly developed procedures and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 Abdominal Aortic Aneurysm Repair Devices Market was ... 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The endovascular stent ... dominate the market during the study period. Continue Reading ... ... ...
(Date:3/24/2017)... 2017 New England Pediatric Device Consortium (NEPDC) ... including funding and in-kind service towards the commercialization of ... "Making blood draws less traumatic for children could ... experience better.  We,re looking forward to working with Velano ... care for the kids we treat," said Ann-Christine ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Wound ... report to their offering. ... The global wound care market was worth $24,482.9 million in 2015 and ... Among the various wound care products type, the advanced wound ... 2015. Among the various applications, surgical wound segment held the largest share ...
Breaking Medicine Technology: